Rigel Pharmaceuticals Inc. is a highly innovative biotechnology company that specializes in the development of novel small molecule drugs for the treatment of immune and hematological disorders. With a strong track record of successful clinical trials, Rigel is dedicated to improving the lives of patients and has a promising future in the pharmaceutical industry.
